#ASCO26 truly embodied the theme of translating science into global patient outcomes. We are grateful to the ~46,000 attendees, all working tirelessly to conquer cancer together! A heartfelt thanks to all. 💗 We can’t wait to see you next year at #ASCO27!

We agree with @DrDespina123: in addition to the research, one of the best parts of a meeting is coming together & connecting. Join us at #GI27 to build meaningful global relationships that will shape the future of GI cancer patient care: bit.ly/4zSkoaH

Test your clinical knowledge with a ❓ from our ASCO-SEP Question Bank! Q: Patient (72) starts a TKI for FGFR3-altered urothelial cancer. Next step?

A recent study published in Breast Cancer Research and Treatment examines geographic access to active triple-negative breast cancer trials in the US. The findings highlight regional disparities and the vital role of federal funding. Learn more: bit.ly/4shxJ9L

❤️ What a happy surprise to bump into my dear friend @AbiSivaMD at @ASCO HQ! 🥰 Me for SAC, Abi for LDP! Different meetings, same passion! ❤️ Special thanks to @Emily Touloukian, DO, @SCOS, and @Joanna Metzner-Sadurski, MD, for their support! ❤️ #ASCO #SAC #LDP #SCOS #Advocacy

❤️ So great to reconnect with @Steve Lee at the @ASCO State Affiliate Council meeting! Always wonderful to catch up with friends and fellow oncology advocates! ❤️ @Jasmine Kamboj #ASCO #ASCOAdvocacy

We mourn the passing of @RachnatShroff. We are grateful for being able to honor her legacy through her endowed Young Investigator Award for future biliary cancer researchers. This morning, NBC's @TODAYshow shared @RachnatShroff's inspiring story. Watch the segment: bit.ly/489iN4i

Our draft guideline protocol for “Treatment of Advanced Pancreatic Cancer: ASCO Guideline Update” are now open for public comment. Help us determine the scope of the guideline. Submit your comments to us by November 4. Read and comment: bit.ly/4hQBbor

Milestone unlocked: Our 50th endowed Young Investigator Award is funded! It is with immense gratitude to our individual donors, foundations and organizations that we announce that Conquer Cancer has officially funded 50 endowed Young Investigator Awards. This milestone ensures that through these grants, 50 early-career researchers will receive dedicated funding each year into the future. Read the announcement and learn what comes next: bit.ly/4igxrf3

ICYMI: Health insurers are initially denying most oral blood cancer Txs and prior auths are cited as the single largest hurdle to this potentially lifesaving care! Write to your lawmakers to urge them to #FixPriorAuth: bit.ly/4dRSOSs #ASCOAdvocacy

ASCO Leads: Latin America applications open! Apply by 10/26 to join us in Costa Rica Feb. 11-12, 2027, for leadership training & premier networking. Designed for mid-career ASCO Members currently practicing oncology in the Latin America region. Learn more: bit.ly/4ynK1ig

Our draft guideline recommendations for “Perioperative Systemic Therapy for Non-Metastatic Renal Cell Carcinoma” are now open for public comment. Help us refine these standards of care. Submit your comments to us by November 3. Read and comment: bit.ly/4ylVcIj

The future of govt relations for @asco is bright! ⭐️And female! 🩷As immediate past chair of the #GRC govt relations cmte, it’s terrific to see Dr Joanna Yang as current chair & Dr Erin Schwab as incoming chair. So much talent! #advocacy

This is why I love these meetings! Great to run into an amazing mentor and leader at @ASCO Wonderful day 1 of chiefs and chairs leadership development day! Looking forward to day 2 @UMMC_Cancer @UMMCnews

Learning lots of practical and strategic wisdom in leadership and team building at the Inaugural ASCO Leads - Program for Oncology Division Chiefs and Department Chairs 10/19 - 10/20/26 at the ASCO Headquarter. @ASCO @LSU

ASCO Members! You now get full access to ASCO Meetings content 30 days post-meeting. Explore the latest science faster! View content from the 2026 ASCO Annual Meeting: bit.ly/4hXg1DS Coming soon: An AI-powered agent from ASCO & Google Cloud to simplify your research.

Our draft guideline recommendations for “Management of Immune-Related Adverse Events- Gastrointestinal and Endocrine Toxicities” are now open for public comment. Submit your comments to us by November 2: bit.ly/4i6DUck

Our @ASCO #LDP mini reunion at #ASCOQLTY26: Drs Minami, @RyanNipp and @minasedrakmd

What a wonderful #ASCOQLTY26! From PROs, AI & #SuppCare to health equity, implementation science & patient-centered care! THANK YOU to all @ASCO staff, speakers, presenters & attendees who made this meeting so special! 👏 Congratulation @RyanNipp on a record-breaking 1,000+ attendees! Looking forward to #ASCOQLTY27 w @WhatsUrHari as Chair!

It was a pleasure to attend my first @ASCO Quality Care Symposium this weekend in Boston! I had the opportunity to present my work with Dr. Simmons at BC Cancer on quality indicators for breast cancer care and learn from inspiring presenters advancing cancer care. #ASCOQLTY2026

Back at @ASCO HQ for the first time since before COVID! Our Government Relations Committee works to advance cancer research funding, sustainable Medicare payment, less prior authorization burden & better access to care. Good cancer policy is essential to good cancer care.